Covid ‘Vaccination’ Linked to 21 Oral Adverse Events

A major pharmacovigilance study published in the International Dental Journal analyzed nearly 1 million adverse event reports submitted to Germany’s Paul-Ehrlich-Institut (PEI) between December 2020 and December 2023

The focus: oral adverse events (AEs) following COVID-19 vaccination—an area largely overlooked in official safety assessments.

Researchers performed a retrospective review of 974,931 individual case safety reports (ICSRs) from the German PEI database.

To validate their findings, they compared oral AE reporting trends to the U.S. VAERS database.

They used both frequentist methods (Proportional Reporting Ratio [PRR], Reporting Odds Ratio [ROR]) and Bayesian signal detection (Information Component [IC]) to identify true safety signals—events reported disproportionately more often than expected compared to all other adverse events.

These reactions were reported far more often than expected, in both German and U.S. vaccine safety databases:

  1. Loss of taste — 18× more likely than expected (PRR: 17.57); 2.2× higher risk after booster (aOR: 2.19)
  2. Complete loss of taste (ageusia) — 16× more likely (PRR: 15.51); 3× higher risk after booster (aOR: 3.00); 3× higher in seniors (aOR: 2.99)
  3. Distorted taste (dysgeusia) — 3× more likely (PRR: 3.31); 3.2× higher risk after booster (aOR: 3.20); 1.3× higher risk in women (aOR: 1.34)
  4. Tingling or numbness in the mouth (oral paraesthesia) — 4.5× more likely (PRR: 4.47); 2.7× higher risk in women (aOR: 2.71); 3.2× higher after booster (aOR: 3.16); 1.5× higher with viral vector vaccines (aOR: 1.54)
  5. Reduced sensitivity in the mouth (oral hypoaesthesia) — 4.3× more likely (PRR: 4.26); 2× higher risk in women (aOR: 2.04)
  6. Swollen tongue — Nearly 3× more likely (PRR: 2.70); 2.9× higher risk in seniors (aOR: 2.87); 2.1× higher risk in women (aOR: 2.08)
  7. Dry mouth — 2.6× more likely (PRR: 2.59)
  8. Canker sores (aphthous ulcers) — 4.5× more likely (PRR: 4.48); 5.9× higher risk in children (aOR: 5.86); 3.9× higher after booster (aOR: 3.91)
  9. Partial loss of taste (hypogeusia) — 3.6× more likely (PRR: 3.56); 1.8× higher risk in seniors (aOR: 1.80)
  10. Burning mouth sensation (glossodynia) — 2.5× more likely (PRR: 2.49); 3.7× higher risk in women (aOR: 3.68); 3× higher risk in seniors (aOR: 3.00)
  11. Numb mouth (oral anaesthesia) — 8× more likely (PRR: 8.31)
  12. Painful or abnormal mouth sensation (oral dysaesthesia) — Extremely elevated signal (IC: 14.6)
  13. Swelling around the mouth — 3.7× more likely (PRR: 3.68)
  14. Redness of the tongue — 3.6× more likely (PRR: 3.60)
  15. Numbness in teeth (dental paraesthesia) — 10× more likely (PRR: 9.97)
  16. Extreme tooth sensitivity (hyperaesthesia of the teeth) — 9× more likely (PRR: 9.14)
  17. Redness of the lips — 2.6× more likely (PRR: 2.59)
  18. Lip irritation/disorder — Nearly 4× more likely (PRR: 3.92)
  19. Itchy mouth (oral pruritus) — 2.4× more likely (PRR: 2.39)
  20. Dry, cracked lips (chapped lips) — 2.5× more likely (PRR: 2.53)
  21. Erosion or breakdown of oral tissue (oral mucosal erosion) — Strong signal (IC: 9.38)

Mechanisms

The authors suggest several biological explanations:

  • Neuroinflammation or demyelination of cranial nerves
  • Spike protein interaction with oral sensory receptors
  • Immune-mediated reactivation of latent herpes viruses

COVID-19 ‘vaccination’ is associated with a wide array of oral sensory and mucosal adverse events—many of which are frequent, underreported, and unacknowledged in current vaccine product labels or post-marketing surveillance protocols.

See more here thefocalpoints.com

Please Donate Below To Support Our Ongoing Work To Expose The Lies About Covid 19

PRINCIPIA SCIENTIFIC INTERNATIONAL, legally registered in the UK as a company incorporated for charitable purposes. Head Office: 27 Old Gloucester Street, London WC1N 3AX. 

Trackback from your site.

Leave a comment

Save my name, email, and website in this browser for the next time I comment.
Share via
Share via